| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 1520 | 0.2259 |
| 1 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1980 | 0.2208 |
| 2 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 2442 | 0.2138 |
| 3 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 2144 | 0.2134 |
| 4 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 691 | 0.1922 |
| 5 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 529 | 0.1921 |
| 6 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 8191 | 0.1803 |
| 7 | FAMOTITINE | 161 | 0.0547 |
| 8 | DARUNAVIR ETHANOLATE AND COBICISTAT | 72 | 0.0409 |
| 9 | BUFFERED ASPIRIN | 45 | 0.0321 |
| # | Drug class | Count |
|---|---|---|
| 0 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9925 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 3910 |
| 2 | Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] | 3303 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1152 |
| 4 | Corticosteroid [EPC] | 873 |
| 5 | Protease Inhibitor [EPC] | 838 |
| 6 | Proton Pump Inhibitor [EPC] | 588 |
| 7 | Benzodiazepine [EPC] | 566 |
| 8 | RANK Ligand Inhibitor [EPC] | 521 |
| 9 | Vitamin C [EPC] | 461 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9925 | 0.0901 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 3910 | 0.0647 |
| 2 | Bismuth [EPC] | 128 | 0.0230 |
| 3 | Protease Inhibitor [EPC] | 838 | 0.0188 |
| 4 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 5 | Provitamin D2 Compound [EPC] | 368 | 0.0124 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 22 | 0.0106 |
| 7 | Antidiarrheal [EPC] | 2 | 0.0084 |
| 8 | Calcitonin [EPC] | 19 | 0.0061 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 12 | 0.0052 |